She also offers 1 0n 1 coaching
doi: 10.3389/fphar.2025.1602976 Received 30 March 2025 Revised 13 November 2025 Accepted 14 November 2025 Published 19 December 2025 Volume 16 - 2025 Edited by Bernd Rosenkranz, Fundisa African Academy of Medicines Development, South Africa Reviewed by Kacper Nijakowski, Poznan University of Medical Sciences, Poland Miriam Njoki Karinja, Science for Africa Foundation, Kenya Updates Copyright 2025 Mazur, Ndokaj, Salerno, Vallone, Ardan, Bietolini, Carrouel, Wilk, Sarig, Ottolenghi and Bourgeois
Genomics 126 LansbergP.LeeA.LeeZ
Pelling, M
This comprehensive approach ensures that researchers can tailor liposomal formulations to specific therapeutic needs, achieving maximum stability, reproducibility, and performance in preclinical studies
Reports indicate severe side effects such as nausea, vomiting, and even hospitalization due to dosing errors and improperly labeled products